Drug Topics- August 11, 2008

8 DRUG TOPICS AUGUST 11, 2008 www.drugtopics.com EDITORIAL E - -C Judy C. Chi (201) 690-5327 jchi@advanstar.com SALES & MARKETING P Rick Stefany (201) 690-5397 rstefany@advanstar.com N S M Maureen Dominguez (201) 690-5328 mdominguez@advanstar.com N S M Carmel Burke-Bonesso (201) 690-5324 cburke-bonesso@advanstar. com S Natalie Roberts (440) 891-2788 M D Susan Haber (201) 690-5403 LM Tamara Phillips (440)891-2773 C R Scott Eigenbrod (800) 225-4569 ext. 3170 C S Karen Eckenwiler (800) 225-4569 ext. 2670 R S Nick Thome (440) 891-2761 or (800) 225-4569 ext. 2761 Fax: (440) 826-2865 nthome@advanstar.com PRODUCTION S P Jane Dzuck (218) 740-6313 CIRCULATION S C S / A C (888) 527-7008 RESEARCH D ,C R Harry Ann Pearce (212) 951-6670 S D M M E Mark Lowery (440) 826-5396 mlowery@advanstar.com Cover Illustration: Jeff Suntala C E Fred Gebhart Jim Plagakis, R.Ph. 24950 Country Club Blvd. North Olmsted, Ohio 44070 Main numbers: (440) 243-8100 or (800) 225-4569 Main fax number: (440) 891-2735 Customer Service: (877) 922-2022 Classified and Recruitment Sales: (800) 225-4569 ext. 2701 E-mail address: drugtopics@advanstar.com Web site: http://www.drugtopics.com Business hours: 8:30 a.m.–5 p.m. EST E E Michael Shaffer (440) 891-2687 D P C Tara Stultz (440) 891-2689 AD Stanley Bujak (440) 891-2790 G AD Pete Seltzer (440) 891-2708 E H R. Steve Morris VP P /S G Laura Wagner P O P C V C Joseph Loggia E O E Ted Alpert VP F , CFO R. Steve Morris VP P /S G V , Francis Heid VP , M O J. Vaughn P , T Mike Alic P , M G E E H Ward D. Hewins VP , G C V Shelbie O’Brien P C V I Nancy Nugent VP H R Drug Topics (ISSN# 0012-6616) is published monthly and Drug Topics Digital Edition (ISSN# 1937-8157) is issued every week by Advanstar Communications, Inc., 131 West First St., Duluth, MN 55806-2065. One-year subscription rates: $61 in the United States & Possessions; $109 in Canada and Mexico; all other countries, $109. Single copies (prepaid only) $10 in the United States; $10 in Canada and Mexico; all other countries, $15. Include $6 per copy for U.S. postage and handling. Periodicals postage paid at Duluth, MN 55806 and additional mailing offices. POSTMASTER: Please send address changes to Drug Topics, P.O. Box 6079, Duluth, MN 55806-6079. Canadian G.S.T. number: R-124213133RT001. Publications Mail Agreement Number 40017597. Printed in the U.S.A. Subscription inquiries/ address changes: toll-free (888) 527-7008, or dial direct (218) 723-9477. Copyright ©2008 Advanstar Communications Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/educational or personal use, or the internal/educational or personal use of specific clients is granted by Advanstar Communications Inc. for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700. For uses beyond those listed above, please direct your written request to Permission Dept. fax 440-891-2650. Microfilm or microfiche copies of issues are available through Advanstar Marketing Services, (800) 225-4569, Ext. 839. Unsolicited manuscripts, photographs, art, and other material will not be returned. Publisher assumes no responsibility for unsolicited manuscripts, photographs, art, and other material. Advanstar Communications provides certain customer contact data (such as customers’ names, addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call toll-free (888) 527-7008 between the hours of 7:30 am and 5 pm CT and a customer service representative will assist you in removing your name from Advanstar’s lists. Outside the U.S., please phone (218) 723-9477. DRUG TOPICS does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance on such content. DRUG TOPICS welcomes unsolicited articles, manuscripts, photographs and other materials but cannot be held responsible for their safekeeping or return. http://www.drugtopics.com http://ampersand.sc http://www.drugtopics.com http://ampersand.sc

Table of Contents Feed for the Digital Edition of Drug Topics- August 11, 2008

Drug Topics- August 11, 2008 Contents Latebreakers Letters DEA Proposes Rule To Allow Electronic Prescriptions for Controlled Substances Merger, Medicare Reform Could Mean Broader E-Prescribing Adoption New Combination Pill Approved for Type 2 Diabetes New Eczema Guildlines Promote Use of Emollients, Then Topical Corticosteroids Agencies Flush Original Strategies in Favor of Promoting Drug Take-Back Programs JP at Large: You Laughing at Me? Pharmacists Find Themselves at Mercy of Prior Authorization State Law Requiring PBM Transparency See Some Gains, Some Losses Global Counterfeiting Still Growing, Says U.S. Commerce Official FDA Saftey Page: Prophylthiouracil Still Confused with Purinethol (mercaptopurine) New Products Bring Lice Treatment to a Head NACDS Marketplace Showcases New Product that Fill Unmet Needs Update on Respiratory Tract Infections Execs Share War Stories About Adopting Technology in their Stores New Products Advertisters Index Classified Viewpoint: Medicare Part D Revisions sorely needed

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.